UB Paderborn / Katalog / Suche / in CDI

Pharmacokinetics and pharmacodynamics of curcumin

Advances in experimental medicine and biology, 2007, Vol.595, p.453

2007

Link zum Volltext

Verfügbarkeit prüfen

Clinical trials of resveratrol

Annals of the New York Academy of Sciences, 2011-01, Vol.1215 (1), p.161-169

2011

Link zum Volltext

Verfügbarkeit prüfen

Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis

Cancer research (Chicago, Ill.), 2010-11, Vol.70 (22), p.9003-9011

2010

Link zum Volltext

Verfügbarkeit prüfen

Resveratrol in the management of human cancer: how strong is the clinical evidence?

Annals of the New York Academy of Sciences, 2013-07, Vol.1290 (1), p.12-20

2013

Link zum Volltext

Verfügbarkeit prüfen

Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer in a Randomized Phase IIa Trial

The Journal of nutrition, 2019-07, Vol.149 (7), p.1133-1139

2019

Link zum Volltext

Verfügbarkeit prüfen

Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice

Science translational medicine, 2015-07, Vol.7 (298), p.298ra117

2015

Link zum Volltext

Verfügbarkeit prüfen

Clinical Pharmacology of Resveratrol and Its Metabolites in Colorectal Cancer Patients

Cancer research (Chicago, Ill.), 2010-10, Vol.70 (19), p.7392-7399

2010

Link zum Volltext

Verfügbarkeit prüfen

Resveratrol in human cancer chemoprevention - Choosing the 'right' dose

Molecular nutrition & food research, 2012-01, Vol.56 (1), p.7-13

2012

Link zum Volltext

Verfügbarkeit prüfen

A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma

British journal of cancer, 2018-03, Vol.118 (6), p.793-801

2018

Link zum Volltext

Verfügbarkeit prüfen

Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial

The lancet oncology, 2014-07, Vol.15 (8), p.829-840

2014

Link zum Volltext

Verfügbarkeit prüfen

Phase I Dose Escalation Pharmacokinetic Study in Healthy Volunteers of Resveratrol, a Potential Cancer Chemopreventive Agent

Cancer epidemiology, biomarkers & prevention, 2007-06, Vol.16 (6), p.1246-1252

2007

Link zum Volltext

Verfügbarkeit prüfen

Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy

Cancer letters, 2015-08, Vol.364 (2), p.135-141

2015

Link zum Volltext

Verfügbarkeit prüfen

Dietary polyphenolic phytochemicals—promising cancer chemopreventive agents in humans? A review of their clinical properties

International journal of cancer, 2007-02, Vol.120 (3), p.451-458

2007

Link zum Volltext

Verfügbarkeit prüfen

Sulfate metabolites provide an intracellular pool for resveratrol generation and induce autophagy with senescence

Science translational medicine, 2013-10, Vol.5 (205), p.205ra133

2013

Link zum Volltext

Verfügbarkeit prüfen

Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer

Journal of clinical oncology, 2009-11, Vol.27 (33), p.5513-5518

2009

Link zum Volltext

Verfügbarkeit prüfen

Rapid Analysis of Curcumin and Curcumin Metabolites in Rat Biomatrices Using a Novel Ultraperformance Liquid Chromatography (UPLC) Method

Journal of agricultural and food chemistry, 2009-02, Vol.57 (3), p.797-803

2009

Link zum Volltext

Verfügbarkeit prüfen

Distribution and metabolism of [14C]-resveratrol in human prostate tissue after oral administration of a “dietary-achievable” or “pharmacological” dose: what are the implications for anticancer activity?

The American journal of clinical nutrition, 2021-05, Vol.113 (5), p.1115-1125

2021

Link zum Volltext

Verfügbarkeit prüfen

Radioembolization of Liver Metastases From Colorectal Cancer Using Yttrium-90 Microspheres With Concomitant Systemic Oxaliplatin, Fluorouracil, and Leucovorin Chemotherapy

Journal of clinical oncology, 2007-03, Vol.25 (9), p.1099-1106

2007

Link zum Volltext

Verfügbarkeit prüfen

Consumption of the Putative Chemopreventive Agent Curcumin by Cancer Patients: Assessment of Curcumin Levels in the Colorectum and their Pharmacodynamic Consequences

Cancer epidemiology, biomarkers & prevention, 2005-01, Vol.14 (1), p.120-125

2005

Link zum Volltext

Verfügbarkeit prüfen

Quantitation of trans-resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007-04, Vol.848 (2), p.182-187

2007

Link zum Volltext

Verfügbarkeit prüfen

Phase I clinical trial of oral curcumin: Biomarkers of systemic activity and compliance

Clinical cancer research, 2004-10, Vol.10 (20), p.6847-6854

2004

Link zum Volltext

Verfügbarkeit prüfen

Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine

Cancer chemotherapy and pharmacology, 2007-07, Vol.60 (2), p.171-177

2007

Link zum Volltext

Verfügbarkeit prüfen

Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PTK787/ZK 222584 Administered Twice Daily in Patients With Advanced Cancer

Journal of clinical oncology, 2005-06, Vol.23 (18), p.4162-4171

2005

Link zum Volltext

Verfügbarkeit prüfen

Anthocyans from fruits and vegetables – Does bright colour signal cancer chemopreventive activity?

European journal of cancer (1990), 2005-09, Vol.41 (13), p.1931-1940

2005

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Pharmacokinetics and pharmacodynamics of curcumin

Clinical trials of resveratrol

Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis

Resveratrol in the management of human cancer: how strong is the clinical evidence?

Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer in a Randomized Phase IIa Trial

Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice

Clinical Pharmacology of Resveratrol and Its Metabolites in Colorectal Cancer Patients

Resveratrol in human cancer chemoprevention - Choosing the 'right' dose

A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma

Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial

Phase I Dose Escalation Pharmacokinetic Study in Healthy Volunteers of Resveratrol, a Potential Cancer Chemopreventive Agent

Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy

Dietary polyphenolic phytochemicals—promising cancer chemopreventive agents in humans? A review of their clinical properties

Sulfate metabolites provide an intracellular pool for resveratrol generation and induce autophagy with senescence

Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer

Rapid Analysis of Curcumin and Curcumin Metabolites in Rat Biomatrices Using a Novel Ultraperformance Liquid Chromatography (UPLC) Method

Distribution and metabolism of [14C]-resveratrol in human prostate tissue after oral administration of a “dietary-achievable” or “pharmacological” dose: what are the implications for anticancer activity?

Radioembolization of Liver Metastases From Colorectal Cancer Using Yttrium-90 Microspheres With Concomitant Systemic Oxaliplatin, Fluorouracil, and Leucovorin Chemotherapy

Consumption of the Putative Chemopreventive Agent Curcumin by Cancer Patients: Assessment of Curcumin Levels in the Colorectum and their Pharmacodynamic Consequences

Quantitation of trans-resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography

Phase I clinical trial of oral curcumin: Biomarkers of systemic activity and compliance

Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine

Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PTK787/ZK 222584 Administered Twice Daily in Patients With Advanced Cancer

Anthocyans from fruits and vegetables – Does bright colour signal cancer chemopreventive activity?

Suchergebnisse filtern